Boston Children's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT01822769
The hypothesis of this study is that participation in a formal cardiopulmonary rehabilitation program improves aerobic exercise capacity and quality of life over the medium term for patients with congenital heart disease with reduced exercise capacity. To test this hypothesis, subjects will be randomized to either receive a 12-week cardiopulmonary rehabilitation program or standard of care, with interval testing of aerobic capacity and other physiologic markers improved fitness, as well as assessment of quality of life.
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
See Arm Description
See Arm Description
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months (primary)
Cardiac output will be assessed and O2 delivery/extraction will be estimated to define mechanisms of improvement in exercise capacity.
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months
Time frame: Baseline to 3 months (primary)
Time frame: Baseline to 3 months
Time frame: Baseline to 3 months
Time frame: Baseline to 3 months
Survey and accelerometry
Time frame: Baseline to 3 months
Boston Children's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06945003
Behavior, Cardiovascular Abnormalities
Belfast, United Kingdom
View Trial DetailsNCT04769167
Autoimmune Diseases, Cardiovascular Abnormalities
St Louis, Missouri, United States
View Trial DetailsNCT05454501
Behavior, Cardiovascular Abnormalities
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03435354
Behavior, Cardiovascular Abnormalities
Edmonton, Alberta, Canada
View Trial Details